AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Zadaxin increases survival rate in NIH animal model.(Brief Article)
2002 SEP 19 - (NewsRx.com & NewsRx.net) -- SciClone Pharmaceuticals (SCLN) announced the positive results of a breast cancer animal model study using monotherapy Zadaxin as an immune system enhancer.
At the 21-week endpoint of the study, the survival rate was over 4 times as great for the group treated with Zadaxin compared with the control group, 33% versus 8%, and the median survival time for the Zadaxin treated group was 38% greater than that of the control group.
At week 13, the survival rate was 100% for the Zadaxin treated group, double the 50% rate for the control group. At the 21-week endpoint of the study the Zadaxin treated group had significantly increased survival relative to the control group (p=0.04 by Kaplan-Meier analysis).
The study was conducted by Terry W. Moody, PhD, at the National Institutes of Health's (NIH) ...
- Zadaxin increases survival rate in NIH animal model.(National Institutes of...
- Newspaper article from: Cancer Weekly September 17, 2002 700+ words
...the study, the survival rate was over 4 times...compared with the control group, 33% versus 8...than that of the control group. At week 13, the survival rate was 100% for the...rate for the control group. At the 21-week...
- Zadaxin increases survival rate in NIH animal model.(breast cancer...
- Newspaper article from: Immunotherapy Weekly September 18, 2002 700+ words
...the study, the survival rate was over 4 times...compared with the control group, 33% versus 8...than that of the control group. At week 13, the survival rate was 100% for the...rate for the control group. At the 21-week...
- Long-Term Survival Rate Improved in Responders with Hepatitis C.(Brief Article)
- Newspaper article from: Hepatitis Weekly May 29, 2000 700+ words
...patients in the control group died (10 from...However, the control group's survival rated...in an eight year survival rate in the IFN and...eventually had a higher survival rate than the control group * Patients with...
- Long-Term Survival Rate Improved in Responders with Hepatitis C.
- Newspaper article from: Immunotherapy Weekly June 4, 2000 700+ words
...patients in the control group died (10 from...However, the control group's survival rated...in an eight year survival rate in the IFN and...eventually had a higher survival rate than the control group * Patients with...
- Taxotere with cisplatin provides better 2-year survival rate.
- Newspaper article from: Biotech Week August 13, 2003 700+ words
...with a 14% 2-year survival rate with vinorelbine and...scores than those in the control group. In addition, patients...better than those in the control group. This multicenter...Investigators found the median survival rate of patients treated...
- Taxotere(R) With Cisplatin Provides Better Safety Profile, Improved Quality of...
- Press release article from: PR Newswire July 18, 2003 700+ words
...percent two-year survival rate with vinorelbine and...scores than those in the control group. In addition, patients...better than those in the control group. Study Protocol and...Investigators found the median survival rate of patients treated...
- CPR Data Debriefing by Hospital Responders Improves CPR Performance and...
- Press release article from: PR Newswire May 26, 2008 700+ words
...who received post-resuscitation feedback compared to a control group of professionals who did not receive educational intervention...inextricably linked -- the combination is essential to increase the survival rate for victims of cardiac arrest. Q-CPR, available only...
- Pfizer/Avant candidate may increase survival rate in GBM patients.
- Newspaper article from: Pharma Marketletter June 16, 2008 700+ words
...care temozolomide in patients with GBM increased time to progression and overall survival compared with a matched historical control group in these Phase II studies. This treatment is being further studied in a randomized Phase IIb/III trial to confirm these...
